Latest Breaking News On - The university of oklahoma college medicine - Page 1 : comparemela.com

Debra L. Richardson, MD, FACS, FACOG, expands on results with upifitamab rilsodotin in platinum-resistant high-grade serous ovarian cancer.

University of oklahomaUnited statesOklahoma cityDebral richardsonPhasei programOu healthStephenson cancer centerUniversity of oklahoma ou college medicineGynecologic oncologyUpifitamab rilsodotinPlatinum resistant high grade serous ovarian cancerThe university of oklahoma college medicine